SG Americas Securities
GBT

SG Americas Securities’s Global Blood Therapeutics, Inc. GBT Stock Holding History

SG Americas Securities’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,674
Closed -$591K – 3507
2022
Q3 		$591K Sell
8,674
-40,034
-82% -$2.21M 0.01% 1398
2022
Q2 		$1.56M Buy
48,708
+38,996
+402% +$1.14M 0.02% 913
2022
Q1 		$336K Sell
9,712
-16,074
-62% -$481K ﹤0.01% 2135
2021
Q4 		$755K Sell
25,786
-15,838
-38% -$491K ﹤0.01% 1843
2021
Q3 		$1.06M Buy
41,624
+21,905
+111% +$644K 0.01% 1865
2021
Q2 		$691K Buy
19,719
+10,305
+109% +$402K ﹤0.01% 1781
2021
Q1 		$384K Sell
9,414
-21,529
-70% -$990K ﹤0.01% 2194
2020
Q4 		$1.34M Buy
30,943
+24,656
+392% +$1.22M 0.01% 1353
2020
Q3 		$347K Buy
6,287
+3,623
+136% +$230K ﹤0.01% 1859
2020
Q2 		$168K Sell
2,664
-12,720
-83% -$872K ﹤0.01% 2994
2020
Q1 		$786K Buy
15,384
+6,866
+81% +$460K 0.01% 1471
2019
Q4 		$677K Buy
8,518
+5,949
+232% +$353K 0.01% 1545
2019
Q3 		$125K Buy
+2,569
New +$134K ﹤0.01% 2616
2019
Q2 		– Sell
-4,869
Closed -$258K – 3544
2019
Q1 		$258K Sell
4,869
-6,386
-57% -$314K ﹤0.01% 2389
2018
Q4 		$462K Buy
+11,255
New +$422K ﹤0.01% 1920
2018
Q3 		– Sell
-3,357
Closed -$152K – 3550
2018
Q2 		$152K Sell
3,357
-178
-5% -$8.11K ﹤0.01% 2792
2018
Q1 		$171K Sell
3,535
-1,218
-26% -$67.9K ﹤0.01% 2536
2017
Q4 		$187K Sell
4,753
-4,441
-48% -$166K ﹤0.01% 2489
2017
Q3 		$285K Buy
9,194
+906
+11% +$25.5K ﹤0.01% 2288
2017
Q2 		$227K Buy
8,288
+4,014
+94% +$119K ﹤0.01% 2332
2017
Q1 		$157K Sell
4,274
-9,293
-68% -$234K ﹤0.01% 2629
2016
Q4 		$196K Buy
+13,567
New +$238K ﹤0.01% 2364

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SG Americas Securities's GBT Position: Q4 2022 in Review

SG Americas Securities sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 8,674 shares — an estimated $591K sold.

SG Americas Securities first reported a position in GBT in Q4 2016 and held it in 22 quarters. The position peaked at $1.56M in Q2 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • SG Americas Securities reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • SG Americas Securities sold 8,674 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $591K.
  • SG Americas Securities first reported a position in Global Blood Therapeutics, Inc. in Q4 2016 and held it in 22 quarters.
  • SG Americas Securities's Global Blood Therapeutics, Inc. position peaked at $1.56M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.